The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Egoscue Corrective Exercise Prescription on Acute and Short-term Chronic Knee and Hip Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02374034
Recruitment Status : Completed
First Posted : February 27, 2015
Last Update Posted : February 27, 2015
Sponsor:
Information provided by (Responsible Party):
Ron Hager, Brigham Young University

Brief Summary:
The primary purpose of this experimental study was to determine the acute effect following one treatment and the short-term effect after a two-week program of Egoscue corrective exercises on chronic knee and hip pain.

Condition or disease Intervention/treatment Phase
Chronic Pain Other: Corrective exercise Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Egoscue Corrective Exercise Prescription on Acute and Short-term Chronic Knee and Hip Pain
Study Start Date : April 2014
Actual Primary Completion Date : August 2014
Actual Study Completion Date : August 2014


Arm Intervention/treatment
Experimental: Treatment
Experimental group (n=20) completed a corrective exercise routine, as per the Egoscue Method, at least five days per week for two weeks.
Other: Corrective exercise
Participants were assigned to either the exercise group, which performed Egoscue corrective exercises for two weeks, or the control group, which did not receive any treatment for two weeks.

No Intervention: Control
The control group maintained their current lifestyle for the two-week duration of the study.



Primary Outcome Measures :
  1. Change in function and pain [ Time Frame: two weeks ]
    Pain and function will be assessed with the WOMAC, a self-administered, multidimensional questionnaire


Secondary Outcome Measures :
  1. Changes in daily pain [ Time Frame: two weeks ]
    The VAS will be daily to assess changes in pain over a two week period



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 71 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • participants with either or both of chronic hip and knee pain
  • pain will be defined as pain on most days of the week for at least 12 weeks

Exclusion Criteria:

  • undergone a knee or hip surgery or had sustained a knee or hip injury in the past 12 months
  • currently receiving any form of pain treatment such as physiotherapy, chiropractic, intraarticular injections, or prescription pain medications
  • exhibited a severe lack of mobility
  • reported an initial pain level < 3 cm on the Visual Analog Scale (VAS) scale
  • pregnant
  • unable to understand English
Publications:
Layout table for additonal information
Responsible Party: Ron Hager, Associate Professor, Brigham Young University
ClinicalTrials.gov Identifier: NCT02374034    
Other Study ID Numbers: X13-0032
First Posted: February 27, 2015    Key Record Dates
Last Update Posted: February 27, 2015
Last Verified: February 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Pain
Pain
Neurologic Manifestations